Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of
Join us to learn more about financial assistance programs for patients and caregivers traveling to obtain treatment or enroll in a clinical trial; and funding
The Meso Foundation’s Executive Director Julie Powers came up with 10 questions to ask during her interview with our Patient Services Director Shannon Sinclair, RN,
In this MesoTV episode, we are joined by Dr. Marjorie Zauderer, a medical oncologist at Memorial Sloan Kettering Cancer Center. Dr. Zauderer talks about the
Two young mesothelioma patients talk about the moment that led up to their diagnosis, how they learned about the Meso Foundation, and how getting a
This MesoTV episode addresses the topic of radiation therapy for the treatment of mesothelioma. The Meso Foundation’s on-staff mesothelioma expert Shannon Sinclair, RN, BSN, OCN,
“We are at a point where in the next few years we’re going to have a lot more options for our patients,” said Dr. Hedy
The Meso Foundation has joined together with hundreds of other rare disease advocacy organizations as part of Rare Disease Week 2022.Julie Powers, Meso Foundation Executive